{"disease":{"id":"histologically-confirmed-cervical-cancer-figo-stage-ib3-iia2-iib-iiic-and-assessed-by-the-researcher-as-resectable-lesion","name":"histologically confirmed cervical cancer figo stage ib3 iia2 iib iiic and assessed by the researcher as resectable lesion"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07104149","title":"Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":29,"lead_sponsor_name":"The First Affiliated Hospital of Zhengzhou University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}